A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 5 filings in this group are Form 4s for Globus Medical, Inc.
The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.
Across the 5 insider filings shown, the breakdown is 3 open-market sale, 1 option exercise and 1 gift. 3 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.
What each transaction type means
- Open-market sale ×3
- The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
- Option exercise ×1
- The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.
- Gift ×1
- Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.
Form 4
Open-market sale
Insider Selling
2026-09-16
GMED insider TOBIN JAMES R (Director) sold 30,000 shares (~$2.24M)
TOBIN JAMES R, listed as Director at GLOBUS MEDICAL INC, reported an open-market sale of 30,000 GMED shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
M |
Option exercise
|
15,000 |
$53.75 |
$806.2K |
M |
Option exercise
|
15,000 |
$63.68 |
$955.2K |
S |
Open-market sale
|
30,000 |
$74.58 |
$2.24M |
M |
Option exercise
derivative · Stock Option (Right to Buy Class A Common Stock)
|
15,000 |
— |
— |
M |
Option exercise
derivative · Stock Option (Right to Buy Class A Common Stock)
|
15,000 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: TOBIN JAMES R (Director)
Shares: 30,000
Est. Value: $2.24M
Form 4
Open-market sale
Insider Selling
2026-08-19
GMED insider ZARRILLI STEPHEN T (Director) sold 25,000 shares (~$2.18M)
ZARRILLI STEPHEN T, listed as Director at GLOBUS MEDICAL INC, reported an open-market sale of 25,000 GMED shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
M |
Option exercise
|
25,000 |
$53.27 |
$1.33M |
S |
Open-market sale
|
25,000 |
$87.04 |
$2.18M |
M |
Option exercise
derivative · Stock Option (Right to Buy Class A Common Stock)
|
25,000 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: ZARRILLI STEPHEN T (Director)
Shares: 25,000
Est. Value: $2.18M
Form 4
Gift
Tax / Compensation Filing
2026-07-28
GMED insider Form 4 filed for equity award, exercise, or tax withholding
Davidar David D (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
G |
Gift
|
2,500 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: Davidar David D (Director)
Shares: 2,500
Form 4
Open-market sale
Insider Selling
2026-06-09
GMED insider Davidar David D (Director) sold 25,000 shares (~$2.02M)
Davidar David D, listed as Director at GLOBUS MEDICAL INC, reported an open-market sale of 25,000 GMED shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
M |
Option exercise
|
25,000 |
$26.27 |
$656.8K |
S |
Open-market sale
|
25,000 |
$80.76 |
$2.02M |
M |
Option exercise
derivative · Stock Option (Right to Buy Class A Common Stock)
|
25,000 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: Davidar David D (Director)
Shares: 25,000
Est. Value: $2.02M
Form 4
Option exercise
Tax / Compensation Filing
2026-06-08
GMED insider Form 4 filed for equity award, exercise, or tax withholding
RHOADS ANN D (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
M |
Option exercise
|
25,000 |
$26.27 |
$656.8K |
M |
Option exercise
derivative · Stock Option (Right to Buy Class A Common Stock)
|
25,000 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: RHOADS ANN D (Director)
Shares: 25,000